Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics

China only approved its first biosimilar drug in 2019, but the market is already looking too crowded for one Big Pharma company. Pfizer has halted its biosimilar programs in China and is selling a biologics facility there to Chinese CDMO giant WuXi Biologics, the company said in a statement Wednesday. The “difficult decision” came after a… Read More »

Living with mild hearing loss

Hearing loss is divided into degrees of severity from mild to profound. If you have mild hearing loss, your hearing loss isn’t severe and you can likely “fake it until you make it” in many social situations. However, despite how it sounds, “mild” hearing loss doesn’t mean harmless—it can still have profound effects on your quality… Read More »

Three Feet or Six? Distancing Guideline for Schools Stirs Debate

The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Vaccine Rollout Guidelines After Vaccination Advertisement Continue reading the main story Supported by Continue reading the main story Three Feet or Six? Distancing Guideline for Schools Stirs Debate Some public health officials say it’s time for the C.D.C. to loosen its social distancing guidelines… Read More »